TTD | Drug: D0RU5N

Drug General Information
Drug ID	D0RU5N
Former ID	DNC014885
Drug Name	Beta-1-C-butenyl-1-deoxygalactonojirimycin
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530905]
Structure		Download 2D MOL 3D MOL
Formula	C11H21NO3
Canonical SMILES	CC1C(NC(C(C1O)O)CO)CCC=C
InChI	1S/C11H21NO3/c1-3-4-5-8-7(2)10(14)11(15)9(6-13)12-8/h3,7-15H,1,4-6H2,2H3/t7-,8-,9+,10+,11-/m0/s1
InChIKey	DJRPURFURDDUBK-DAWVFNFOSA-N
PubChem Compound ID	46906931
Target and Pathway
Target(s)	Alpha-galactosidase A	Target Info	Inhibitor	[530905]
KEGG Pathway	Galactose metabolism
	Glycerolipid metabolism
	Sphingolipid metabolism
	Glycosphingolipid biosynthesis - globo series
	Lysosome
PathWhiz Pathway	Sphingolipid Metabolism
PathWhiz Pathway	Galactose Metabolism
Reactome	Glycosphingolipid metabolism
WikiPathways	Sphingolipid metabolism
References
Ref 530905	Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. Epub 2010 Apr 21.2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.
Ref 530905	Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. Epub 2010 Apr 21.2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information